- Home
- NLSP vs PLAG Comparison
NLSP vs PLAG Comparison
Compare NLSP & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- PLAG
- Stock Information
- Founded
- NLSP 2015
- PLAG 1986
- Country
- NLSP Switzerland
- PLAG United States
- Employees
- NLSP N/A
- PLAG N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- PLAG Packaged Foods
- Sector
- NLSP Health Care
- PLAG Consumer Staples
- Exchange
- NLSP Nasdaq
- PLAG Nasdaq
- Market Cap
- NLSP 12.4M
- PLAG 12.8M
- IPO Year
- NLSP 2021
- PLAG N/A
- Fundamental
- Price
- NLSP $2.07
- PLAG $1.65
- Analyst Decision
- NLSP
- PLAG
- Analyst Count
- NLSP 0
- PLAG 0
- Target Price
- NLSP N/A
- PLAG N/A
- AVG Volume (30 Days)
- NLSP 179.9K
- PLAG 78.4K
- Earning Date
- NLSP 10-17-2025
- PLAG 08-14-2025
- Dividend Yield
- NLSP N/A
- PLAG N/A
- EPS Growth
- NLSP N/A
- PLAG N/A
- EPS
- NLSP N/A
- PLAG N/A
- Revenue
- NLSP N/A
- PLAG $6,069,007.00
- Revenue This Year
- NLSP N/A
- PLAG N/A
- Revenue Next Year
- NLSP N/A
- PLAG N/A
- P/E Ratio
- NLSP N/A
- PLAG N/A
- Revenue Growth
- NLSP N/A
- PLAG N/A
- 52 Week Low
- NLSP $1.30
- PLAG $0.47
- 52 Week High
- NLSP $6.97
- PLAG $5.52
- Technical
- Relative Strength Index (RSI)
- NLSP 42.25
- PLAG 48.39
- Support Level
- NLSP $2.03
- PLAG $1.61
- Resistance Level
- NLSP $2.29
- PLAG $1.81
- Average True Range (ATR)
- NLSP 0.18
- PLAG 0.19
- MACD
- NLSP -0.06
- PLAG -0.02
- Stochastic Oscillator
- NLSP 3.88
- PLAG 28.00
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.